A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced or Metastatic Solid Tumors|Lung Cancer|Breast Cancer|Head and Neck Squamous Cell Carcinoma|Endometrial Cancer|Melanoma|CRC|Urothelial Carcinoma|Cholangiocarcinoma
Interventions: DRUG: NC318
Sponsor: NextCure, Inc.